Summit Therapeutics (SMMT)
NASDAQ:SMMT
US Market
Holding SMMT?
Track your performance easily

Summit Therapeutics (SMMT) Cash flow

879 Followers

Summit Therapeutics Cash Flow

SMMT's free cash flow for Q2 2024 was $-33.06M. For the 2024 fiscal year, SMMT's free cash flow was decreased by $-34.46M and operating cash flow was $-33.00M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -97.49M$ -76.76M$ -41.58M$ -72.59M$ -48.11M$ -20.75M
Investing Cash Flow
$ -123.13M$ -587.77M$ -624.00K$ -306.00K$ -421.00K$ -339.00K
Financing Cash Flow
$ 207.18M$ 86.51M$ 620.24M$ 77.92M$ 50.55M$ 49.51M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 186.31M$ 71.42M$ 648.61M$ 71.79M$ 66.42M$ 63.85M
Income Tax Paid Supplemental Data
-$ 52.00K-$ 7.00K$ -70.00K$ 63.00K
Interest Paid Supplemental Data
$ 7.36M$ 10.65M$ 434.00K$ 85.00K--
Issuance Of Capital Stock
$ 205.00M$ 109.69M$ 100.00M$ 75.00M$ 50.00M$ 50.41M
Issuance Of Debt
-$ -24.69M$ 519.96M$ -54.00K--
Repayment Of Debt
-$ -24.69M$ -25.04M$ -110.05M--
Free Cash Flow
$ -78.15M$ -76.66M$ -42.21M$ -72.89M$ -48.53M$ -21.09M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Summit Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis